Would the elderly be better off if they were given more placebos?
- PMID: 20100289
- DOI: 10.1111/j.1447-0594.2009.00580.x
Would the elderly be better off if they were given more placebos?
Abstract
Placebos are useful in the medical care of the elderly, although the exact definition of a "placebo" or "placebo effect" is difficult to define precisely. They have an important role as control treatments in research trials, but a non-specific "placebo effect" may also be beneficial part of many physician-patient interactions. Physicians also give them deliberately according to several studies worldwide to satisfy patient demands or because they believe in a "placebo effect" among other reasons. A significant placebo effect has been observed among older patients in clinical trials of antidepressants (12-15%), and in treatments of Parkinson's disease (16%). Placebos activate serotonergic pathways in the brain used by antidepressants. In Parkinson's disease, the administration of a placebo stimulates dopamine release in the dorsal (resulting in motor effects) and ventral striatum (which influences expectation of reward). Much of our understanding of the placebo effect comes from studies of placebo analgesia which is influenced by conditioning, expectation, meaning and context of the treatment for the patient, and patient-physician interaction. It is anatomically medicated by brain opioid pathways. Response to "sham" acupuncture in osteoarthritis may be an example of its use in the elderly. Placebos have often been considered a deception and thus unethical. On the other hand, some physicians and ethicists have suggested conditions for appropriate uses for placebos. A placebo might offer the theoretical advantage of an inexpensive treatment that would not cause adverse drug reactions or interactions with other medications, potentially avoiding complications of polypharmacy.
Similar articles
-
[Placebo, placebo effect and clinical trials].Neurologia. 2007 Mar;22(2):69-71. Neurologia. 2007. PMID: 17323230 Spanish.
-
Placebo analgesia.Neurol Sci. 2006 May;27 Suppl 2:S100-2. doi: 10.1007/s10072-006-0580-4. Neurol Sci. 2006. PMID: 16688609 Review.
-
Placebo effects without placebos? More reason to abandon the paradoxical placebo.Am J Bioeth. 2009 Dec;9(12):50-2. doi: 10.1080/15265160903234151. Am J Bioeth. 2009. PMID: 20013501 No abstract available.
-
The placebo response: neurobiological and clinical issues of neurological relevance.Prog Brain Res. 2009;175:283-94. doi: 10.1016/S0079-6123(09)17520-9. Prog Brain Res. 2009. PMID: 19660663 Review.
-
The legitimacy of placebo treatments in clinical practice: evidence and ethics.Am J Bioeth. 2009 Dec;9(12):39-47. doi: 10.1080/15265160903316263. Am J Bioeth. 2009. PMID: 20013499
Cited by
-
Placebo analgesia: cognitive influences on therapeutic outcome.Arthritis Res Ther. 2012 Mar 30;14(2):206. doi: 10.1186/ar3783. Arthritis Res Ther. 2012. PMID: 22494482 Free PMC article. Review.
-
Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine.Gerontology. 2015;61(2):97-108. doi: 10.1159/000365248. Gerontology. 2015. PMID: 25427869 Free PMC article. Review.
-
Placebos as a Source of Agency: Evidence and Implications.Front Psychiatry. 2019 Oct 25;10:721. doi: 10.3389/fpsyt.2019.00721. eCollection 2019. Front Psychiatry. 2019. PMID: 31708807 Free PMC article. Review.
-
Placebo eff ects in psychiatry: mediators and moderators.Lancet Psychiatry. 2015 Mar;2(3):246-57. doi: 10.1016/S2215-0366(14)00092-3. Lancet Psychiatry. 2015. PMID: 25815249 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources